Back to School: How biopharma can reboot drug development. Access exclusive analysis here
INDICATION: Renal cancer
In vitro and cell culture studies identified an aminothiazole-based negative allosteric modulator (NAM)
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury